Found: 2
Select item for more details and to access through your institution.
Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2‐dependent mechanism.
- Published in:
- Clinical & Translational Medicine, 2023, v. 13, n. 8, p. 1, doi. 10.1002/ctm2.1359
- By:
- Publication type:
- Article
Inhibition of METTL3 attenuates renal injury and inflammation by alleviating TAB3 m6A modifications via IGF2BP2-dependent mechanisms.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 640, p. 1, doi. 10.1126/scitranslmed.abk2709
- By:
- Publication type:
- Article